AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Sep 2, 2021
30442_dirs_2021-09-02_afc28474-31fd-4471-8166-f151afd44034.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-08-31
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-31 | Common Stock | S | 12675 | $182.04 | Disposed | 6002344 | Direct |
| 2021-09-01 | Common Stock | S | 14304 | $186.29 | Disposed | 5988040 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.82 to $185.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.575 to $187.78. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.